Critical appraisal of the role of fingolimod in the treatment of multiple sclerosis
Clemens Warnke1,2, Olaf Stüve3,4, Hans-Peter Hartung1, Anna Fogdell-Hahn2, Bernd C Kieseier11Department of Neurology, Heinrich-Heine-University, Düsseldorf, Germany; 2Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden; 3Department of Neurology, Dal...
Main Authors: | Warnke C, Stüve O, Hartung HP, Fogdell-Hahn A, Kieseier B |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2011-09-01
|
Series: | Neuropsychiatric Disease and Treatment |
Online Access: | http://www.dovepress.com/critical-appraisal-of-the-role-of-fingolimod-in-the-treatment-of-multi-a8235 |
Similar Items
-
CRITICAL APPRAISAL OF EFFECTIVENESS OF ORAL FINGOLIMOD ON RELAPSING MULTIPLE SCLEROSIS
by: Rizaldy Taslim Pinzon, et al.
Published: (2017-11-01) -
Review of teriflunomide and its potential in the treatment of multiple sclerosis
by: Clemens Warnke, et al.
Published: (2009-05-01) -
Advances in the treatment of relapsing–remitting multiple sclerosis – critical appraisal of fingolimod
by: Gasperini C, et al.
Published: (2013-03-01) -
Fingolimod for the Treatment of Relapsing-Remitting Multiple Sclerosis
by: Burcu Altunrende, et al.
Published: (2017-12-01) -
Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity
by: Verena Isabell Leussink, et al.
Published: (2012-09-01)